{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:17:18Z","timestamp":1791865038486,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515030038"],"award-info":[{"award-number":["2023A1515030038"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016799","name":"Natural Science Foundation of Guangzhou Municipality","doi-asserted-by":"publisher","award":["202201010910"],"award-info":[{"award-number":["202201010910"]}],"id":[{"id":"10.13039\/100016799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272862"],"award-info":[{"award-number":["82272862"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002684"],"award-info":[{"award-number":["82002684"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cisplatin resistance is a major challenge for systemic therapy against advanced bladder cancer (BC). Little information is available on the regulation of cisplatin resistance and the underlying mechanisms require elucidation. Here, we detected that downregulation of the tumor suppressor, PPP2R2B (a serine\/threonine protein phosphatase 2\u00a0A regulatory subunit), in BC promoted cell proliferation and migration. What\u2019s more, low PPP2R2B expression was correlated with cisplatin resistance. In vitro and in vivo experiments verified that PPP2R2B could promote BC sensitivity to cisplatin. In terms of mechanism, we identified a novel function of PPP2R2B as a nucleocytoplasmic transport molecule. PPP2R2B promoted ISG15 entry into the nucleus by mediating binding of IPO5 with ISG15. Nuclear translocation of ISG15 inhibited DNA repair, further increasing ISG15 expression through activation of the STING pathway. Besides, PPP2R2B was down-regulated by SUV39H1-mediated histone 3 lysine 9 trimethylation, which could be restored by the SUV39H1-specific inhibitor, chaetocin. Our data suggest that PPP2R2B expression level is a potential biomarker for chemotherapy response and that chemotherapy in combination with chaetocin may be a feasible treatment strategy for patients with BC.<\/jats:p>","DOI":"10.1007\/s00018-024-05320-1","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T13:02:00Z","timestamp":1720443720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancer"],"prefix":"10.1007","volume":"81","author":[{"given":"Gaowei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anze","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangquan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziran","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8889-5122","authenticated-orcid":false,"given":"Zhenhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"key":"5320_CR1","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD (2020) Bladder Cancer: a review. JAMA 324:1980\u20131991. https:\/\/doi.org\/10.1001\/jama.2020.17598","journal-title":"JAMA"},{"key":"5320_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R et al (2021) European Association of Urology Guidelines on muscle-invasive and metastatic bladder Cancer: Summary of the 2020 guidelines. Eur Urol 79:82\u2013104. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.055","journal-title":"Eur Urol"},{"key":"5320_CR3","doi-asserted-by":"publisher","first-page":"10474","DOI":"10.1158\/0008-5472.CAN-10-2855","volume":"70","author":"AA Sablina","year":"2010","unstructured":"Sablina AA, Hector M, Colpaert N, Hahn WC (2010) Identification of PP2A complexes and pathways involved in cell transformation. Cancer Res 70:10474\u201310484. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2855","journal-title":"Cancer Res"},{"key":"5320_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ccr.2010.10.021","volume":"18","author":"J Tan","year":"2010","unstructured":"Tan J, Lee PL, Li Z et al (2010) B55\u03b2-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer. Cancer Cell 18:459\u2013471. https:\/\/doi.org\/10.1016\/j.ccr.2010.10.021","journal-title":"Cancer Cell"},{"key":"5320_CR5","doi-asserted-by":"publisher","first-page":"101105","DOI":"10.1016\/j.redox.2019.101105","volume":"27","author":"D Raman","year":"2019","unstructured":"Raman D, Pervaiz S (2019) Redox inhibition of protein phosphatase PP2A: potential implications in oncogenesis and its progression. Redox Biol 27:101105. https:\/\/doi.org\/10.1016\/j.redox.2019.101105","journal-title":"Redox Biol"},{"key":"5320_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41388-021-02068-x","volume":"41","author":"P Amin","year":"2022","unstructured":"Amin P, Awal S, Vigneron S et al (2022) PP2A-B55: substrates and regulators in the control of cellular functions. Oncogene 41:1\u201314. https:\/\/doi.org\/10.1038\/s41388-021-02068-x","journal-title":"Oncogene"},{"key":"5320_CR7","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1038\/s41467-020-19704-x","volume":"11","author":"Y Bao","year":"2020","unstructured":"Bao Y, Oguz G, Lee WC et al (2020) EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy. Nat Commun 11:5878. https:\/\/doi.org\/10.1038\/s41467-020-19704-x","journal-title":"Nat Commun"},{"key":"5320_CR8","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3892\/ijo.2011.950","volume":"38","author":"S Jung","year":"2011","unstructured":"Jung S, Jeong H-K, Shin J, Lee M-S (2011) Effect of PP2A on p34SEI-1 expression in response to ionizing radiation in MCF-7 human breast cancer cells. Int J Oncol 38:1475\u20131482. https:\/\/doi.org\/10.3892\/ijo.2011.950","journal-title":"Int J Oncol"},{"key":"5320_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13062-024-00461-6","volume":"19","author":"D Shen","year":"2024","unstructured":"Shen D, Kang S (2024) Comprehensive analysis of mitochondria-related genes indicates that PPP2R2B is a novel biomarker and promotes the progression of bladder cancer via wnt signaling pathway. Biol Direct 19:17. https:\/\/doi.org\/10.1186\/s13062-024-00461-6","journal-title":"Biol Direct"},{"key":"5320_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1590\/S1677-5538.IBJU.2022.0373","volume":"49","author":"Y Hao","year":"2023","unstructured":"Hao Y, Wang C, Xu D (2023) Identification and validation of a novel prognostic model based on platinum resistance-related genes in bladder cancer. Int Braz J Urol 49:61\u201388. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2022.0373","journal-title":"Int Braz J Urol"},{"key":"5320_CR11","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1038\/s41388-021-02055-2","volume":"40","author":"D Huang","year":"2021","unstructured":"Huang D, Savage SR, Calinawan AP et al (2021) A highly annotated database of genes associated with platinum resistance in cancer. Oncogene 40:6395\u20136405. https:\/\/doi.org\/10.1038\/s41388-021-02055-2","journal-title":"Oncogene"},{"key":"5320_CR12","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.1318376111","volume":"111","author":"JS Damrauer","year":"2014","unstructured":"Damrauer JS, Hoadley KA, Chism DD et al (2014) Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci U S A 111:3110\u20133115. https:\/\/doi.org\/10.1073\/pnas.1318376111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5320_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507:315\u2013322. https:\/\/doi.org\/10.1038\/nature12965","journal-title":"Nature"},{"key":"5320_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Kim J, Al-Ahmadie H et al (2017) Comprehensive molecular characterization of muscle-invasive bladder Cancer. Cell 171:540\u2013556e25. https:\/\/doi.org\/10.1016\/j.cell.2017.09.007","journal-title":"Cell"},{"key":"5320_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S et al (2014) Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25:152\u2013165. https:\/\/doi.org\/10.1016\/j.ccr.2014.01.009","journal-title":"Cancer Cell"},{"key":"5320_CR16","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1038\/s41598-018-22126-x","volume":"8","author":"N-A-D Marzouka","year":"2018","unstructured":"Marzouka N-A-D, Eriksson P, Rovira C et al (2018) A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort. Sci Rep 8:3737. https:\/\/doi.org\/10.1038\/s41598-018-22126-x","journal-title":"Sci Rep"},{"key":"5320_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reyni\u00e8s A, Allory Y et al (2020) A Consensus Molecular classification of muscle-invasive bladder Cancer. Eur Urol 77:420\u2013433. https:\/\/doi.org\/10.1016\/j.eururo.2019.09.006","journal-title":"Eur Urol"},{"key":"5320_CR18","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S et al (2021) clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb) 2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141","journal-title":"Innov (Camb)"},{"key":"5320_CR19","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1038\/s41467-020-18640-0","volume":"11","author":"A Taber","year":"2020","unstructured":"Taber A, Christensen E, Lamy P et al (2020) Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis. Nat Commun 11:4858. https:\/\/doi.org\/10.1038\/s41467-020-18640-0","journal-title":"Nat Commun"},{"key":"5320_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nprot.2006.5","volume":"1","author":"PL Olive","year":"2006","unstructured":"Olive PL, Ban\u00e1th JP (2006) The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 1:23\u201329. https:\/\/doi.org\/10.1038\/nprot.2006.5","journal-title":"Nat Protoc"},{"key":"5320_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364\u2013378. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.025","journal-title":"Eur J Pharmacol"},{"key":"5320_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13046-022-02284-7","volume":"41","author":"IC Salaroglio","year":"2022","unstructured":"Salaroglio IC, Belisario DC, Bironzo P et al (2022) SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma. J Exp Clin Cancer Res 41:75. https:\/\/doi.org\/10.1186\/s13046-022-02284-7","journal-title":"J Exp Clin Cancer Res"},{"key":"5320_CR23","doi-asserted-by":"publisher","first-page":"18992","DOI":"10.1074\/jbc.M011703200","volume":"276","author":"P Douglas","year":"2001","unstructured":"Douglas P, Moorhead GB, Ye R, Lees-Miller SP (2001) Protein phosphatases regulate DNA-dependent protein kinase activity. J Biol Chem 276:18992\u201318998. https:\/\/doi.org\/10.1074\/jbc.M011703200","journal-title":"J Biol Chem"},{"key":"5320_CR24","doi-asserted-by":"publisher","first-page":"e202002175","DOI":"10.1083\/jcb.202002175","volume":"219","author":"MC Raso","year":"2020","unstructured":"Raso MC, Djoric N, Walser F et al (2020) Interferon-stimulated gene 15 accelerates replication fork progression inducing chromosomal breakage. J Cell Biol 219:e202002175. https:\/\/doi.org\/10.1083\/jcb.202002175","journal-title":"J Cell Biol"},{"key":"5320_CR25","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1038\/s41467-022-33535-y","volume":"13","author":"CP Wardlaw","year":"2022","unstructured":"Wardlaw CP, Petrini JHJ (2022) ISG15 conjugation to proteins on nascent DNA mitigates DNA replication stress. Nat Commun 13:5971. https:\/\/doi.org\/10.1038\/s41467-022-33535-y","journal-title":"Nat Commun"},{"key":"5320_CR26","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1172\/JCI61762","volume":"122","author":"YJ Jeon","year":"2012","unstructured":"Jeon YJ, Jo MG, Yoo HM et al (2012) Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15. J Clin Invest 122:2622\u20132636. https:\/\/doi.org\/10.1172\/JCI61762","journal-title":"J Clin Invest"},{"key":"5320_CR27","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/s12276-022-00872-3","volume":"54","author":"JA Kang","year":"2022","unstructured":"Kang JA, Kim YJ, Jeon YJ (2022) The diverse repertoire of ISG15: more intricate than initially thought. Exp Mol Med 54:1779\u20131792. https:\/\/doi.org\/10.1038\/s12276-022-00872-3","journal-title":"Exp Mol Med"},{"key":"5320_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/bib\/bbz169","volume":"22","author":"S Lin","year":"2021","unstructured":"Lin S, Wang C, Zhou J et al (2021) EPSD: a well-annotated data resource of protein phosphorylation sites in eukaryotes. Brief Bioinform 22:298\u2013307. https:\/\/doi.org\/10.1093\/bib\/bbz169","journal-title":"Brief Bioinform"},{"key":"5320_CR29","doi-asserted-by":"publisher","first-page":"10171","DOI":"10.1073\/pnas.0900604106","volume":"106","author":"S Kosugi","year":"2009","unstructured":"Kosugi S, Hasebe M, Tomita M, Yanagawa H (2009) Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs. Proc Natl Acad Sci U S A 106:10171\u201310176. https:\/\/doi.org\/10.1073\/pnas.0900604106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5320_CR30","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1074\/jbc.M807017200","volume":"284","author":"S Kosugi","year":"2009","unstructured":"Kosugi S, Hasebe M, Matsumura N et al (2009) Six classes of nuclear localization signals specific to different binding grooves of importin alpha. J Biol Chem 284:478\u2013485. https:\/\/doi.org\/10.1074\/jbc.M807017200","journal-title":"J Biol Chem"},{"key":"5320_CR31","doi-asserted-by":"publisher","first-page":"8484","DOI":"10.1093\/nar\/gks598","volume":"40","author":"H-W Chao","year":"2012","unstructured":"Chao H-W, Lai Y-T, Lu Y-L et al (2012) NMDAR signaling facilitates the IPO5-mediated nuclear import of CPEB3. Nucleic Acids Res 40:8484\u20138498. https:\/\/doi.org\/10.1093\/nar\/gks598","journal-title":"Nucleic Acids Res"},{"key":"5320_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13046-019-1290-0","volume":"38","author":"W Zhang","year":"2019","unstructured":"Zhang W, Lu Y, Li X et al (2019) IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation. J Exp Clin Cancer Res 38:296. https:\/\/doi.org\/10.1186\/s13046-019-1290-0","journal-title":"J Exp Clin Cancer Res"},{"key":"5320_CR33","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.1224026","volume":"337","author":"D Bogunovic","year":"2012","unstructured":"Bogunovic D, Byun M, Durfee LA et al (2012) Mycobacterial disease and impaired IFN-\u03b3 immunity in humans with inherited ISG15 deficiency. Science 337:1684\u20131688. https:\/\/doi.org\/10.1126\/science.1224026","journal-title":"Science"},{"key":"5320_CR34","doi-asserted-by":"publisher","first-page":"e1010921","DOI":"10.1371\/journal.ppat.1010921","volume":"18","author":"H Liu","year":"2022","unstructured":"Liu H, Li C, He W et al (2022) Free ISG15 inhibits Pseudorabies virus infection by positively regulating type I IFN signaling. PLoS Pathog 18:e1010921. https:\/\/doi.org\/10.1371\/journal.ppat.1010921","journal-title":"PLoS Pathog"},{"key":"5320_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.molcel.2020.07.026","volume":"80","author":"T Reisl\u00e4nder","year":"2020","unstructured":"Reisl\u00e4nder T, Groelly FJ, Tarsounas M (2020) DNA damage and Cancer immunotherapy: a STING in the Tale. Mol Cell 80:21\u201328. https:\/\/doi.org\/10.1016\/j.molcel.2020.07.026","journal-title":"Mol Cell"},{"key":"5320_CR36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41580-022-00483-w","volume":"23","author":"J Padeken","year":"2022","unstructured":"Padeken J, Methot SP, Gasser SM (2022) Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance. Nat Rev Mol Cell Biol 23:623\u2013640. https:\/\/doi.org\/10.1038\/s41580-022-00483-w","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5320_CR37","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.3390\/cancers12102792","volume":"12","author":"P Das","year":"2020","unstructured":"Das P, Taube JH (2020) Regulating methylation at H3K27: a trick or treat for Cancer Cell plasticity. Cancers (Basel) 12:2792. https:\/\/doi.org\/10.3390\/cancers12102792","journal-title":"Cancers (Basel)"},{"key":"5320_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nchembio721","volume":"1","author":"D Greiner","year":"2005","unstructured":"Greiner D, Bonaldi T, Eskeland R et al (2005) Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3\u20139. Nat Chem Biol 1:143\u2013145. https:\/\/doi.org\/10.1038\/nchembio721","journal-title":"Nat Chem Biol"},{"key":"5320_CR39","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/leu.2011.271","volume":"26","author":"H Chaib","year":"2012","unstructured":"Chaib H, Nebbioso A, Prebet T et al (2012) Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1. Leukemia 26:662\u2013674","journal-title":"Leukemia"},{"key":"5320_CR40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.apsb.2020.09.015","volume":"11","author":"J Wang","year":"2021","unstructured":"Wang J, Yin X, He W et al (2021) SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis. Acta Pharm Sin B 11:406\u2013419. https:\/\/doi.org\/10.1016\/j.apsb.2020.09.015","journal-title":"Acta Pharm Sin B"},{"key":"5320_CR41","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s41419-019-2107-y","volume":"10","author":"E Ozyerli-Goknar","year":"2019","unstructured":"Ozyerli-Goknar E, Sur-Erdem I, Seker F et al (2019) The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma. Cell Death Dis 10:894. https:\/\/doi.org\/10.1038\/s41419-019-2107-y","journal-title":"Cell Death Dis"},{"key":"5320_CR42","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41419-019-2035-x","volume":"10","author":"C Wen","year":"2019","unstructured":"Wen C, Wang H, Wu X et al (2019) ROS-mediated inactivation of the PI3K\/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin. Cell Death Dis 10:809. https:\/\/doi.org\/10.1038\/s41419-019-2035-x","journal-title":"Cell Death Dis"},{"key":"5320_CR43","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1182\/blood-2006-07-027326","volume":"109","author":"CR Isham","year":"2007","unstructured":"Isham CR, Tibodeau JD, Jin W et al (2007) Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress. Blood 109:2579\u20132588. https:\/\/doi.org\/10.1182\/blood-2006-07-027326","journal-title":"Blood"},{"key":"5320_CR44","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I et al (2012) Molecular mechanisms of cisplatin resistance. Oncogene 31:1869\u20131883. https:\/\/doi.org\/10.1038\/onc.2011.384","journal-title":"Oncogene"},{"key":"5320_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nature10760","volume":"481","author":"CJ Lord","year":"2012","unstructured":"Lord CJ, Ashworth A (2012) The DNA damage response and cancer therapy. Nature 481:287\u2013294. https:\/\/doi.org\/10.1038\/nature10760","journal-title":"Nature"},{"key":"5320_CR46","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1200\/JCO.18.02050","volume":"37","author":"C Gourley","year":"2019","unstructured":"Gourley C, Balma\u00f1a J, Ledermann JA et al (2019) Moving from poly (ADP-Ribose) polymerase inhibition to targeting DNA repair and DNA damage response in Cancer Therapy. J Clin Oncol 37:2257\u20132269. https:\/\/doi.org\/10.1200\/JCO.18.02050","journal-title":"J Clin Oncol"},{"key":"5320_CR47","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1021\/bi00229a001","volume":"30","author":"RE Mayer","year":"1991","unstructured":"Mayer RE, Hendrix P, Cron P et al (1991) Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: evidence for a neuronal-specific isoform. Biochemistry 30:3589\u20133597. https:\/\/doi.org\/10.1021\/bi00229a001","journal-title":"Biochemistry"},{"key":"5320_CR48","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1158\/0008-5472.CAN-13-1263","volume":"74","author":"Y Tan","year":"2014","unstructured":"Tan Y, Sun D, Jiang W et al (2014) PP2A-B55\u03b2 antagonizes cyclin E1 proteolysis and promotes its dysregulation in cancer. Cancer Res 74:2006\u20132014. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1263","journal-title":"Cancer Res"},{"key":"5320_CR49","doi-asserted-by":"publisher","first-page":"11315","DOI":"10.1016\/S0021-9258(18)60961-5","volume":"262","author":"AL Haas","year":"1987","unstructured":"Haas AL, Ahrens P, Bright PM, Ankel H (1987) Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 262:11315\u201311323","journal-title":"J Biol Chem"},{"key":"5320_CR50","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1016\/S0021-9258(18)42585-9","volume":"267","author":"KR Loeb","year":"1992","unstructured":"Loeb KR, Haas AL (1992) The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 267:7806\u20137813","journal-title":"J Biol Chem"},{"key":"5320_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2018.09.007","volume":"438","author":"HG Han","year":"2018","unstructured":"Han HG, Moon HW, Jeon YJ (2018) ISG15 in cancer: beyond ubiquitin-like protein. Cancer Lett 438:52\u201362. https:\/\/doi.org\/10.1016\/j.canlet.2018.09.007","journal-title":"Cancer Lett"},{"key":"5320_CR52","doi-asserted-by":"publisher","first-page":"18490","DOI":"10.1073\/pnas.0809242105","volume":"105","author":"RR Weichselbaum","year":"2008","unstructured":"Weichselbaum RR, Ishwaran H, Yoon T et al (2008) An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A 105:18490\u201318495. https:\/\/doi.org\/10.1073\/pnas.0809242105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5320_CR53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tig.2015.10.007","volume":"32","author":"M Lawrence","year":"2016","unstructured":"Lawrence M, Daujat S, Schneider R (2016) Lateral thinking: how histone modifications regulate Gene expression. Trends Genet 32:42\u201356. https:\/\/doi.org\/10.1016\/j.tig.2015.10.007","journal-title":"Trends Genet"},{"key":"5320_CR54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13059-019-1870-5","volume":"20","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, Shilatifard A (2019) Epigenetic modifications of histones in cancer. Genome Biol 20:245. https:\/\/doi.org\/10.1186\/s13059-019-1870-5","journal-title":"Genome Biol"},{"key":"5320_CR55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jpha.2022.11.009","volume":"13","author":"Q Liao","year":"2023","unstructured":"Liao Q, Yang J, Ge S et al (2023) Novel insights into histone lysine methyltransferases in cancer therapy: from epigenetic regulation to selective drugs. J Pharm Anal 13:127\u2013141. https:\/\/doi.org\/10.1016\/j.jpha.2022.11.009","journal-title":"J Pharm Anal"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05320-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-024-05320-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05320-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T13:20:18Z","timestamp":1720444818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-024-05320-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5320"],"URL":"https:\/\/doi.org\/10.1007\/s00018-024-05320-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"assertion":[{"value":"13 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Surgical specimens from patients with BC were from the Department of Urology, First Affiliated Hospital, Sun Yat-sen University and the informed consent was obtained from each patient. All in vivo experimental procedures were ethically compliant and approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"292"}}